Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
NVCR
#1845
NovoCure Limited Ordinary Shares
13.670
0
+2.78%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+2.78%
Monatliche Änderung
+4.75%
6 month change
-0.58%
Jahresänderung
-0.58%
Vorheriger Schlusskurs
13.300
0
Open
13.670
0
Bid
Ask
Low
13.670
0
High
13.670
0
Volumen
177
Märkte
Aktien
Gesundheitswesen
NVCR
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
108.2 M
109.92 M
111.49 M
111.8 M
111.98 M
113.79 M
—
Valuation ratios
Enterprise value
1.51 B
3.11 B
1.86 B
1.84 B
1.1 B
1.38 B
6.18 B
Price to earnings ratio
-11.16
-19.1
-11.8
-11.41
-8.02
-10.6
-41.83
Price to sales ratio
2.9
5.31
3.1
3.08
2.21
—
—
Price to cash flow ratio
-28.76
-121.87
-38.1
-29.89
-18.89
29.4
-57.48
Price to book ratio
1.16
8.92
1.34
1.36
1.01
4.23
7.93
Enterprise value to EBITDA ratio
-11.35
-19.24
-13.29
-12.58
-7.34
—
—
Profitability ratios
Return on assets %
0.03
0.05
0.03
0.03
0.03
0.03
0.12
Return on equity %
0.08
0.18
0.09
0.11
0.11
0.07
0.39
Return on invested capital %
37.53
38.87
21.54
22.45
21.99
44.7
110.67
Gross margin %
77.19
79.25
75.15
73.88
73.25
75.82
298.1
Operating margin %
20.69
39.25
24.43
24.89
21.54
23.17
94.03
EBITDA margin %
-16.35
-35.12
-20.14
-20.82
-17.71
-21.02
-79.69
Net margin %
19.71
40.88
22.14
25.28
22.29
14.05
83.76
Liquidity ratios
Quick ratio
1.44
1.42
1.41
1.39
1.5
2.71
7.01
Current ratio
1.49
1.46
1.47
1.45
1.55
2.9
7.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.13
0.12
0.13
0.13
0.16
0.54
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0.08
0.08
0.08
0.14
0.24
0.54
Long term debt to total equity ratio
0.27
0.27
0.27
0.28
0.57
0.57
1.69
Per share metrics
Operating cash flow per share
0.1
-0.16
0.32
0.14
0.18
-0.21
0.44
EBIT per share
-0.3
-0.59
-0.34
-0.35
-0.32
-0.36
-1.38
EBITDA per share
-0.23
-0.53
-0.28
-0.3
-0.26
-0.33
-1.17
Total debt per share
—
—
—
—
—
—
—
Cash per share
8.87
8.9
8.43
8.17
9.24
4.02
29.85
Net current asset value per share
10.12
10.26
9.88
9.71
10.72
5.8
36.11
Tangible book value per share
3.33
3.34
3.28
3.13
3.05
3.05
12.52
Working capital per share
3.33
3.25
3.14
2.99
3.79
3.8
13.71
Book value per share
3.33
3.34
3.28
3.13
3.05
3.05
12.52
Nachrichten
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Novocure Ltd earnings beat by $0.19, revenue topped estimates
Netflix and Palantir among market cap stock movers on Wednesday
Novocure vor Quartalszahlen: Markteinführung der Therapie gegen Bauchspeicheldrüsenkrebs im Fokus/n
Novocure earnings up next: Pancreatic cancer launch in focus
Oracle and Netflix among market cap stock movers on Wednesday
Novocure-Aktie springt an: Medicare-Abrechnungsbefugnis wiederhergestellt
Novocure stock jumps after Medicare billing restored
Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching